|
AFAP1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.382900E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.596700E-04 |
| Normal-vs-Stage2 |
5.829200E-01 |
| Normal-vs-Stage3 |
6.518000E-03 |
| Normal-vs-Stage4 |
3.553700E-02 |
| Stage1-vs-Stage2 |
1.185240E-01 |
| Stage1-vs-Stage3 |
8.757600E-01 |
| Stage1-vs-Stage4 |
4.964000E-01 |
| Stage2-vs-Stage3 |
1.627430E-01 |
| Stage2-vs-Stage4 |
3.462400E-01 |
| Stage3-vs-Stage4 |
6.422000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.11160000000277E-05 |
| Normal-vs-AfricanAmerican |
2.272300E-02 |
| Normal-vs-Asian |
1.789630E-01 |
| Caucasian-vs-AfricanAmerican |
6.631600E-01 |
| Caucasian-vs-Asian |
1.882570E-01 |
| AfricanAmerican-vs-Asian |
2.055200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.445700E-02 |
| Normal-vs-Female |
6.206100E-04 |
| Male-vs-Female |
3.475000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.034900E-04 |
| Normal-vs-Age(41-60Yrs) |
5.836500E-03 |
| Normal-vs-Age(61-80Yrs) |
3.928200E-01 |
| Normal-vs-Age(81-100Yrs) |
1.005410E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.025240E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.919600E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.931400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.651600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.868000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.774000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.121400E-01 |
| Classical-VS-Follicular |
3.98348021235506E-13 |
| Classical-VS-Other |
6.351600E-01 |
| Classical-VS-Normal |
1.46530000000311E-06 |
| Tall-VS-Follicular |
3.69490000040607E-07 |
| Tall-VS-Other |
4.469600E-01 |
| Tall-VS-Normal |
2.566800E-04 |
| Follicular-VS-Other |
4.440400E-02 |
| Follicular-VS-Normal |
4.148000E-02 |
| Other-VS-Normal |
1.841040E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.782970E-01 |
| Normal-vs-N1 |
2.308100E-02 |
| N0-vs-N1 |
1.088380E-01 |
|
|
